Key Highlights
- TailorMed secures $40M in financing, combining equity and debt.
- Windham Capital Partners led the round, joined by Citi Impact Fund, Samsung Next, and others.
- Investment supports TailorMed’s mission to eliminate barriers to care and affordability.
- Platform addresses cost barriers at every stage of the medication journey.
- Nation’s largest affordability network, deployed in 800+ hospitals and 1,300 clinics.
Source: Business Wire
Notable Quotes
- “This new funding will fuel our mission to break down even more barriers to care, creating a healthcare system where affordability is the standard, not the exception, and working with patients and care teams to alleviate whatever barrier that comes next.” — Srulik Dvorsky, CEO and Co-Founder at TailorMed
- “TailorMed has a history of driving transformational change to address the critical challenges in the healthcare system and our nation’s affordability crisis. We are inspired to see the company taking a bold leap forward to tackle all barriers to care.” — Adam Fine, Founder and General Partner, Windham Capital Partners
- “TailorMed’s platform ensures all patients can access essential treatment without delay or facing bankruptcy.” — David Kereiakes, Managing Partner, Windham Capital Partners
SoHC's Take
TailorMed’s ability to integrate across the entire medication journey positions it as a leader in tackling one of the healthcare industry’s most pressing challenges—affordability. The $40M investment, supported by top-tier health systems and investors, underscores the confidence in TailorMed’s innovative approach to uniting patients, providers, and life sciences. This funding not only expands their reach but also accelerates the transition toward a healthcare system where no patient is denied care due to cost barriers.
